Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Merck Sharp & Dohme LLC
Age
0–0
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Is Healthy, based on clinical judgment of the investigator
Has a legally acceptable representative who understands the study procedures, alternate treatments available, and risks involved with the study and voluntarily agrees to participate by giving written informed consent.
You may not be if
Has a history of invasive pneumococcal disease (positive blood culture, positive cerebrospinal fluid culture, or other sterile site) or known history of other culture positive pneumococcal disease
Has a known hypersensitivity to any component of the pneumococcal conjugate vaccine (PCV), any component of the licensed pediatric vaccines to be administered concomitantly in the study, or any diphtheria toxoid-containing vaccine
Has any contraindication to the concomitant study vaccines being administered in the study
Has a known or suspected impairment of immunological function
Has a history of congenital or acquired immunodeficiency
Has or his/her mother has a documented human immunodeficiency virus (HIV) infection
Has or his/her mother has a documented hepatitis B surface antigen - positive test
Has known or history of functional or anatomic asplenia
Has failure to thrive based on the clinical judgment of the investigator
Has a known coagulation disorder contraindicating intramuscular vaccination
Has a history of autoimmune disease (including but not limited to systemic lupus erythematosus, antiphospholipid syndrome, Behcet's disease, autoimmune thyroid disease, polymyositis and dermatomyositis, scleroderma, type 1 diabetes mellitus, or other autoimmune disorders)
Has a known neurologic or cognitive behavioral disorder, including encephalitis/myelitis, acute disseminating encephalomyelitis, pervasive development disorder, and related disorders
Has received a dose of any pneumococcal vaccine prior to study entry
Has received \>1 dose of monovalent hepatitis B vaccine or hepatitis B based combination vaccine prior to study entry
Has received a dose of rotavirus vaccine prior to study entry
Has received a blood transfusion or blood products, including immunoglobulins
Has participated in another clinical study of an investigational product before the beginning or anytime during the duration of the current clinical study
Has any other reason that, in the opinion of the investigator, may interfere with the evaluation required by the study
Has an immediate family member (e.g., parent/legal guardian or sibling) who is investigational site or Sponsor staff directly involved with this study.
